Link between GSL antigens and tumor survival in breast cancer found in a new research

Biologics |  News | 0 Comment | 19 Feb, 2019

A team led by Dr. Chi-Huey Wong, Distinguished Research Fellow, Academia Sinica in Taiwan, in collaboration with OBI scientists, has demonstrated in a recent study that the Globo-series gly...Read more

Chipscreen Biosciences unites with Innovent for colorectal cancer therapy

Biologics |  News | 0 Comment | 18 Feb, 2019

Chipscreen Biosciences, a leading integrated Chinese biotech company specialized in discovery and development of novel small molecule pharmaceuticals with a primary focus in oncology, metab...Read more

Singapore researchers reveal role of anti-parasitic drug in treating cancer

Biologics |  News | 0 Comment | 15 Feb, 2019

Scientists from A*STAR’s Institute of Molecular and Cell Biology (IMCB) have discovered that niclosamide, an FDA-approved anti-parasitic drug, can effectively kill p53-defective cance...Read more

Researchers develop potential therapeutic model for Parkinson’s disease

Biologics |  News | 0 Comment | 12 Feb, 2019

Parkinson's disease (PD) is the second most common neurodegenerative disorder, implicating 10 million people worldwide but has no cure at present. The main reason for this is the difficulty...Read more

Duke-NUS researchers reveal novel immune study on dengue

Biologics |  News | 0 Comment | 08 Feb, 2019

Researchers at Duke-NUS Medical School have demonstrated for the first time a physical interaction between two types of immune cells that plays an important role in the early fight against ...Read more

NUS researchers study nanoparticles’ role in cancer metastasis

Biologics |  News | 0 Comment | 04 Feb, 2019

Nanoparticles can be found in processed food (e.g. food additives), consumer products (e.g. sunscreen) and even in medicine. While these tiny particles could have large untapped potential a...Read more

Researchers in Japan develop strategy to strengthen skeletal muscles

Biologics |  News | 0 Comment | 01 Feb, 2019

Hokkaido University researchers have developed a strategy to fabricate materials that become stronger in response to mechanical stress mimicking skeletal muscle growth. Their findings could...Read more

Alvotech raises $300mn to further biosimilar development

Biologics |  News | 0 Comment | 24 Jan, 2019

Alvotech has successfully raised US$300 million through a private bond offering. Net proceeds from the capital raised will be used to fuel continued growth, refinance of existing debt and...Read more

Novel device by NUS aids in muscle recovery

Biologics |  News | 0 Comment | 24 Jan, 2019

A team of NUS researchers has developed a novel medical device capable of harnessing a magnetic field to make muscle rehabilitation quicker and more comfortable. MRegen is a non-invasive p...Read more

I-Mab Biopharma gets USFDA IND nod for antibody TJD5

Biologics |  News | 0 Comment | 23 Jan, 2019

China-based clinical stage biopharmaceutical company, I-Mab Biopharma, exclusively focused on the development of innovative biologics in immuno-oncology and autoimmune diseases, announ...Read more

Mechanical stress may affect normal bone development

Biologics |  News | 0 Comment | 21 Jan, 2019

The bone matrix contains various proteins, namely, collagen and other non-collagenous proteins. Osteoblasts are responsible for producing these materials. At early stages of development the...Read more

Branched-Chain amino acids can regulate progression of Cancer: Research

Biologics |  News | 0 Comment | 21 Jan, 2019

Researchers at A*STAR's Singapore Bioimaging Consortium (SBIC) have discovered that branched-chain amino acids (BCAAs) in tumours can be targeted to prevent and treat cancer. Together with ...Read more

Ribon Therapeutics raises $65M

Biologics |  News | 0 Comment | 07 Jan, 2019

Ribon Therapeutics, a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activated under cellular stress conditions has announced the closing of a ...Read more

Tizona Therapeutics appoints Scott Clarke as CEO

Biologics |  News | 0 Comment | 05 Jan, 2019

US based biotech company, Tizona Therapeutics has announced that Scott Clarke has joined the company as its chief executive officer. Clarke joins from Roche where he served as the Global He...Read more

Betta Pharma uses ProBioGen's technology for cancer treatment

Biologics |  News | 0 Comment | 03 Jan, 2019

ProBioGen AG, a premier service & technology provider for complex therapeutic antibodies and glycoproteins, announced that the company achieved an undisclosed milestone payment from Mer...Read more

Roswell Biotech secures $32 million series A financing round

Biologics |  News | 0 Comment | 03 Jan, 2019

Roswell Biotechnologies, Inc., the pioneer in the development of a molecular electronics platform for DNA Sequencing, has closed a $32 million round of Series A financing backed b...Read more

Innovent, Eli Lilly announce co-development of Tyvyt

Biologics |  News | 0 Comment | 28 Dec, 2018

Innovent Biologics and Eli Lilly and Company have jointly announced that the co-developed Tyvyt (fully human anti-PD-1 therapeutic monoclonal antibody, generic name: sintilimab injection) h...Read more

Researchers discover new compound to treat breast cancer

Biologics |  News | 0 Comment | 13 Dec, 2018

A novel compound against breast cancer improves the efficacy of standard cancer treatment and shows superior tolerability in laboratory tests when compared to similar agents, setting the st...Read more